Effect of Zoledronic and Ibandronic Acids on Bone Metabolism in Women With Postmenopausal Osteoporosis

Osteoporosis and Bone Diseases
doi 10.14341/osteo2012221-24
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Endocrinology Research Centre

Related search

Effect of Denosumab on Trabecular Bone Score in Postmenopausal Women With Osteoporosis

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2017English

Bone Metabolism Genes Variation and Response to Bisphosphonate Treatment in Women With Postmenopausal Osteoporosis

PLoS ONE
Multidisciplinary
2019English

Curative Effect Analysis of Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis With Different Bone Turnover Rates

International Journal of Clinical Medicine
2018English

Effects of Denosumab on Bone Density, Mass and Strength in Women With Postmenopausal Osteoporosis

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2015English

Bone Mass and Mineral Metabolism in HIV+ Postmenopausal Women

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2005English

Effects of Alendronate on the Markers of Bone Metabolic Activity in Postmenopausal Women With Osteoporosis

Medicinski Pregled
Medicine
2005English

Osteoporosis in Postmenopausal Women Living With HIV

Maturitas
BiochemistryGynecologyGeneticsObstetricsMolecular Biology
2017English

Once-Yearly Zoledronic Acid in the Prevention of Osteoporotic Bone Fractures in Postmenopausal Women

Clinical Interventions in Aging
MedicineGerontologyGeriatrics
2008English

The Effect of Osteoporosis on Cochlear Function in Postmenopausal Women: An Observational Study

Journal of Surgery and Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy